The effect of astragaloside IV on a model of isoproterenol-induced hypertrophic injury in H9c2 cells
Acta Pharmaceutica · 01.03.2026 · 76 (1) · 1-12
DOI: 10.2478/acph-2026-0006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 25.03.2026. Verfasst von Yang Long und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Pharmacy, Xing Yi People's Hospital, Xing Yi, 562499, P.R. China. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Myocytes, Cardiac, Isoproterenol. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The objective of this study was to explore the protective effect of astragaloside IV on a model of isoproterenol-induced (ISO) hyper-trophic injury in rat cardiomyocytes H9c2 (cell line derived from embryonic BD1X rat heart tissue). A cell hypertrophy injury model was established (H9c2 cells treated with 100 μmol L–1 ISO). The cells were divided into normal control, a model group, and an astragalo-side IV group at several concentrations. Astragaloside IV was pre-administered for 2 hours, followed by ISO treatment for 24 hours. Cell viability, cell surface area, apoptosis rate, lactate dehydrogenase (LDH) activity, reactive oxygen species (ROS), superoxide dismutase (SOD), the mRNA levels of Bcl-2, Bax, p62, and LC3, the protein expressions of Sirt1, p62, caspase-3, beclin, and p53 and the LC3II/LC3I ratio were detected. Astragaloside IV significantly alleviated ISO-induced hypertrophy injury in H9c2 cells, reduced cell surface area and LDH release, decreased apoptosis rate and intracellular ROS levels, increased SOD levels, upregulated the expressions of autophagy-related mRNA and proteins, and downregulated the expressions of apoptosis-related mRNA and proteins. Astragaloside IV can effectively inhibit ISO-induced hypertrophy and apoptosis in H9c2 cells, and its mechanism may be related to promoting auto-phagy and reducing oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Pharmacy, Xing Yi People's Hospital, Xing Yi, 562499, P.R. China.
- 2Orthopedic Joint Surgery Xing Yi People's Hospital Xing Yi, 562499, P.R. China.
- 3Cardiovascular Medicine Department, Xing Yi People's Hospital, Xing Yi, 562499 P.R. China.
- 4Affiliated Hospital of Sichuan Nursing Vocational College (The Third People's Hospital of Sichuan Province), Chengdu City SiChuan Province, 610100 P.R. China.
Zitieren
APA
Long, Y., Xiao, Y., Chen, C., Peng, C., & Zhang, Y. (2026). The effect of astragaloside IV on a model of isoproterenol-induced hypertrophic injury in H9c2 cells. Acta Pharmaceutica, 76(1), 1-12. https://doi.org/10.2478/acph-2026-0006
Vancouver
Long Y, Xiao Y, Chen C, Peng C, Zhang Y. The effect of astragaloside IV on a model of isoproterenol-induced hypertrophic injury in H9c2 cells. Acta Pharmaceutica. 2026;76(1):1-12. doi:10.2478/acph-2026-0006
BibTeX
@article{Long2026,
author = {Long, Yang and Xiao, Yuan and Chen, Chun and Peng, Chao and Zhang, Yuxi},
title = {The effect of astragaloside IV on a model of isoproterenol-induced hypertrophic injury in H9c2 cells},
journal = {Acta Pharmaceutica},
year = {2026},
volume = {76},
number = {1},
pages = {1--12},
doi = {10.2478/acph-2026-0006}
}
EUVIMED